• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体腺瘤中 和 家族基因的表达:临床相关性和术后结果。

The expression of and family genes in pituitary adenomas: clinical correlations and postsurgical outcomes.

机构信息

Post-Graduate Program in Adult Health (PPGSAD), Federal University of Maranhão (UFMA), São Luis, Brazil.

Service of Endocrinology, University Hospital of the Federal University of Maranhao (HUUFMA), São Luis, Brazil.

出版信息

Front Endocrinol (Lausanne). 2024 Oct 10;15:1481050. doi: 10.3389/fendo.2024.1481050. eCollection 2024.

DOI:10.3389/fendo.2024.1481050
PMID:39449743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11499145/
Abstract

INTRODUCTION

Pituitary adenomas (PAs) are benign tumors with high prevalence and, occasionally, aggressive course. The tumorigenesis of these lesions is not completely understood at the molecular level. BAK1 and BAX proteins play fundamental roles in apoptosis and seem to interact with VDAC proteins, whose expressions have been markedly altered in cancer, impacting their prognosis.

OBJECTIVE

to evaluate the gene expression of and and their association with clinical and imaging characteristics in PA.

METHODS

Clinical-epidemiological data were collected from 117 tumor samples from patients affected by PA. Invasiveness was assessed by the Knosp scale. Gene expression was examined by real-time PCR. Relative expression analysis was performed by 2^(-DDCt) method.

RESULTS

The sample was mainly composed of women (69/117 - 57.2%). Tumor subtypes observed were Non-Functioning (NF) (73/117 - 62.4%), Acromegaly (24/117 - 20.5%) and Cushing's Disease (CD) (20/117 - 17.1%). Compared to normal tissue, there was a significant reduction in expression in the Acromegaly (p=0.029) and NF (p=0.002) groups. expression was lower in all groups (p <0.001; p=0.007; P =0.005). No difference was found in and expression, compared to normal pituitary. Overexpression of occurred in PAs with post-surgical regrowth (p=0.042). A strongly negative correlation was observed in and expression in CD.

CONCLUSION

The results indicated that downregulations of and may be related to resistance to apoptosis. In contrast, overexpression of in regrowing PAs suggests an antiapoptotic role for this gene. In summary, the genes evaluated might be involved in the biopathology of PAs.

摘要

简介

垂体腺瘤(PA)是一种常见的良性肿瘤,偶尔会出现侵袭性病程。这些病变的肿瘤发生机制在分子水平上尚未完全阐明。BAK1 和 BAX 蛋白在细胞凋亡中发挥着重要作用,并且似乎与 VDAC 蛋白相互作用,后者在癌症中的表达发生了明显改变,影响了其预后。

目的

评估 和 在 PA 中的基因表达及其与临床和影像学特征的相关性。

方法

从 117 例 PA 患者的肿瘤样本中收集临床流行病学数据。通过 Knosp 量表评估侵袭性。通过实时 PCR 检查基因表达。通过 2^(-DDCt)方法进行相对表达分析。

结果

样本主要由女性组成(69/117-57.2%)。观察到的肿瘤亚型是非功能性(NF)(73/117-62.4%)、肢端肥大症(24/117-20.5%)和库欣病(CD)(20/117-17.1%)。与正常组织相比,肢端肥大症(p=0.029)和 NF 组(p=0.002)中 的表达显著降低。所有组的 表达均降低(p<0.001;p=0.007;p=0.005)。与正常垂体相比, 与 表达无差异。术后复发的 PA 中 过表达(p=0.042)。CD 中观察到 与 表达呈强烈负相关。

结论

结果表明, 和 的下调可能与抗细胞凋亡有关。相反,在复发性 PA 中 过表达表明该基因具有抗凋亡作用。综上所述,所评估的基因可能参与 PA 的生物病理学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9473/11499145/abd5f649126e/fendo-15-1481050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9473/11499145/be3e12fa9093/fendo-15-1481050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9473/11499145/abd5f649126e/fendo-15-1481050-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9473/11499145/be3e12fa9093/fendo-15-1481050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9473/11499145/abd5f649126e/fendo-15-1481050-g002.jpg

相似文献

1
The expression of and family genes in pituitary adenomas: clinical correlations and postsurgical outcomes.垂体腺瘤中 和 家族基因的表达:临床相关性和术后结果。
Front Endocrinol (Lausanne). 2024 Oct 10;15:1481050. doi: 10.3389/fendo.2024.1481050. eCollection 2024.
2
The proteomic 2D-DIGE approach reveals the protein voltage-dependent anion channel 2 as a potential therapeutic target in epithelial thyroid tumours.蛋白质组二维差异凝胶电泳方法揭示了电压依赖性阴离子通道蛋白2是甲状腺上皮肿瘤的一个潜在治疗靶点。
Mol Cell Endocrinol. 2015 Mar 15;404:37-45. doi: 10.1016/j.mce.2015.01.021. Epub 2015 Jan 21.
3
N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.垂体腺瘤中N-myc下游调控基因2(NDRG2)的启动子甲基化与表达
Diagn Pathol. 2017 Apr 8;12(1):33. doi: 10.1186/s13000-017-0622-7.
4
Structure-based modeling of turnover of Bcl-2 family proteins bound to voltage-dependent anion channel 2 (VDAC2): Implications for the mechanisms of proapoptotic activation of Bak and Bax in vivo.基于结构的 Bcl-2 家族蛋白与电压依赖性阴离子通道 2(VDAC2)结合物周转率建模:对 Bak 和 Bax 在体内促凋亡激活机制的影响。
Comput Biol Chem. 2020 Apr;85:107203. doi: 10.1016/j.compbiolchem.2020.107203. Epub 2020 Jan 13.
5
VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria.VDAC2 通过将 BAK 招募到线粒体中来介导截断型 BID 诱导的线粒体凋亡。
EMBO Rep. 2009 Dec;10(12):1341-7. doi: 10.1038/embor.2009.219. Epub 2009 Oct 9.
6
Bax targets mitochondria by distinct mechanisms before or during apoptotic cell death: a requirement for VDAC2 or Bak for efficient Bax apoptotic function.在凋亡性细胞死亡之前或期间,Bax通过不同机制作用于线粒体:高效发挥Bax凋亡功能需要VDAC2或Bak。
Cell Death Differ. 2014 Dec;21(12):1925-35. doi: 10.1038/cdd.2014.119. Epub 2014 Aug 22.
7
VDAC2 enables BAX to mediate apoptosis and limit tumor development.VDAC2 使 BAX 能够介导细胞凋亡并限制肿瘤的发展。
Nat Commun. 2018 Nov 26;9(1):4976. doi: 10.1038/s41467-018-07309-4.
8
Expression of the Bcl-2 family genes and complexes involved in the mitochondrial transport in prostate cancer cells.参与前列腺癌细胞线粒体转运的Bcl-2家族基因及复合物的表达
Int J Oncol. 2014 Oct;45(4):1489-96. doi: 10.3892/ijo.2014.2576.
9
Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas: an immunohistochemical study.垂体腺瘤中Bcl-2、Bax和p53蛋白的表达:一项免疫组织化学研究。
Tumori. 2003 Jan-Feb;89(1):54-9. doi: 10.1177/030089160308900112.
10
Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells.Bcl-x(S) 通过破坏 VDAC2-Bak 相互作用介导黑素瘤细胞中凋亡的有效诱导。
Cell Death Differ. 2012 Dec;19(12):1928-38. doi: 10.1038/cdd.2012.71. Epub 2012 Jun 15.

引用本文的文献

1
Recent advances in craniopharyngioma pathophysiology and emerging therapeutic approaches.颅咽管瘤病理生理学的最新进展及新兴治疗方法
Front Endocrinol (Lausanne). 2025 May 13;16:1562942. doi: 10.3389/fendo.2025.1562942. eCollection 2025.

本文引用的文献

1
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.靶向瓦伯格效应:从分子机制到癌症传统与创新治疗策略的新视角
Acta Pharm Sin B. 2024 Mar;14(3):953-1008. doi: 10.1016/j.apsb.2023.12.003. Epub 2023 Dec 16.
2
A Novel Preoperative Score to Predict Long-Term Biochemical Remission in Patients with Growth-Hormone Secreting Pituitary Adenomas.一种预测生长激素型垂体腺瘤患者长期生化缓解的新型术前评分。
World Neurosurg. 2024 Feb;182:e882-e890. doi: 10.1016/j.wneu.2023.12.076. Epub 2023 Dec 18.
3
Non-functioning pituitary macroadenoma following surgery: long-term outcomes and development of an optimal follow-up strategy.
手术后无功能垂体大腺瘤:长期预后及最佳随访策略的制定
Front Surg. 2023 Jul 12;10:1129387. doi: 10.3389/fsurg.2023.1129387. eCollection 2023.
4
VDAC as a voltage-dependent mitochondrial gatekeeper under physiological conditions.VDAC 作为一种在生理条件下电压依赖性的线粒体门卫。
Biochim Biophys Acta Biomembr. 2023 Aug;1865(6):184175. doi: 10.1016/j.bbamem.2023.184175. Epub 2023 May 17.
5
Diagnosis and Management of Pituitary Adenomas: A Review.垂体腺瘤的诊断与管理:综述
JAMA. 2023 Apr 25;329(16):1386-1398. doi: 10.1001/jama.2023.5444.
6
Tumour microenvironment and pituitary tumour behaviour.肿瘤微环境与垂体肿瘤行为
J Endocrinol Invest. 2023 Jun;46(6):1047-1063. doi: 10.1007/s40618-023-02089-1. Epub 2023 Apr 15.
7
VDAC as a Cellular Hub: Docking Molecules and Interactions.VDAC 作为细胞枢纽:对接分子和相互作用。
Int J Mol Sci. 2023 Apr 2;24(7):6649. doi: 10.3390/ijms24076649.
8
Mitochondrial pores at the crossroad between cell death and inflammatory signaling.线粒体孔在细胞死亡和炎症信号之间的十字路口。
Mol Cell. 2023 Mar 16;83(6):843-856. doi: 10.1016/j.molcel.2023.02.021.
9
Aggressive pituitary tumors (PitNETs).侵袭性垂体肿瘤(垂体神经内分泌肿瘤)
Endocr J. 2023 Mar 28;70(3):241-248. doi: 10.1507/endocrj.EJ23-0007. Epub 2023 Mar 3.
10
The hallmarks of cancer… in pituitary tumors?癌症的特征……在垂体肿瘤中?
Rev Endocr Metab Disord. 2023 Apr;24(2):177-190. doi: 10.1007/s11154-022-09777-y. Epub 2022 Dec 31.